… A meta-analysis of all included randomised controlled trials was performed. Four … were
included for meta-analysis. The results of the meta-analysis indicated that the moxifloxacin was …

… In conclusion, despite the limitations of our meta-analysis, we conclude that moxifloxacin
monotherapy has similar clinical efficacy and favourable microbiological treatment success …

… Monotherapy is not recommended by the guidelines and only a few studies have evaluated
the efficacy and safety of moxifloxacin … meta-analysis suggests that addition of moxifloxacin …

… We conclude that once-daily moxifloxacin monotherapy is as effective as the currently used
regimens in the treatment of uPID. In comparison, moxifloxacin may be considered as a more …

… To investigate whether moxifloxacin monotherapy is associated with better clinical outcomes
than other antibiotics recommended for CAP among adults with mild-to-moderate or severe …

… the meta-analysis showed that the moxifloxacin monotherapy … The drug-related adverse
of moxifloxacin was significantly … meta-analysis, we can draw a conclusion that moxifloxacin …

… In conclusion, despite some limitations in our meta-analysis, we conclude that sequential
iv/po moxifloxacin monotherapy is an effective and relatively safe option for the treatment of …

… and patients are treated with either intravenous (IV) moxifloxacin or levofloxacin monotherapy
as initial antibiotic treatment. Moxifloxacin and levofloxacin are prescribed as 0.4 g and 0.5 …

… meta-analysis, we found that the side effects and the number of patients discontinuing therapy
because of side effects in the moxifloxacin … of these antibiotics as monotherapy for other …

… moxifloxacin monotherapy versus ß-lactam monotherapy, as well as moxifloxacin monotherapy
versus any other monotherapy … Analyses were controlled for possible therapy selection …